191 related articles for article (PubMed ID: 12091344)
1. Functional characterization of recombinant FV Hong Kong and FV Cambridge.
Norstrøm E; Thorelli E; Dahlbäck B
Blood; 2002 Jul; 100(2):524-30. PubMed ID: 12091344
[TBL] [Abstract][Full Text] [Related]
2. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
Egan JO; Kalafatis M; Mann KG
Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
[TBL] [Abstract][Full Text] [Related]
4. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
5. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S.
Tran S; Dahlbäck B
J Thromb Haemost; 2010 Jan; 8(1):129-36. PubMed ID: 19874463
[TBL] [Abstract][Full Text] [Related]
6. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
Segers K; Dahlbäck B; Rosing J; Nicolaes GA
J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572
[TBL] [Abstract][Full Text] [Related]
7. Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
Cramer TJ; Griffin JH; Gale AJ
Pathophysiol Haemost Thromb; 2010; 37(1):17-23. PubMed ID: 20501981
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
[TBL] [Abstract][Full Text] [Related]
9. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.
Gale AJ; Xu X; Pellequer JL; Getzoff ED; Griffin JH
Protein Sci; 2002 Sep; 11(9):2091-101. PubMed ID: 12192065
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
Aparicio C; Dahlbäck B
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
[TBL] [Abstract][Full Text] [Related]
11. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
Steen M; Norstrøm EA; Tholander AL; Bolton-Maggs PH; Mumford A; McVey JH; Tuddenham EG; Dahlbäck B
Blood; 2004 May; 103(9):3381-7. PubMed ID: 14695241
[TBL] [Abstract][Full Text] [Related]
13. Factor V and thrombotic disease: description of a janus-faced protein.
Nicolaes GA; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
[TBL] [Abstract][Full Text] [Related]
14. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
Norstrøm EA; Steen M; Tran S; Dahlbäck B
J Biol Chem; 2003 Jul; 278(27):24904-11. PubMed ID: 12707283
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.
Heeb MJ; Kojima Y; Greengard JS; Griffin JH
Blood; 1995 Jun; 85(12):3405-11. PubMed ID: 7780127
[TBL] [Abstract][Full Text] [Related]
16. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.
Castoldi E; Brugge JM; Nicolaes GA; Girelli D; Tans G; Rosing J
Blood; 2004 Jun; 103(11):4173-9. PubMed ID: 14976057
[TBL] [Abstract][Full Text] [Related]
17. Functional properties of factor V and factor Va encoded by the R2-gene.
Hoekema L; Castoldi E; Tans G; Girelli D; Gemmati D; Bernardi F; Rosing J
Thromb Haemost; 2001 Jan; 85(1):75-81. PubMed ID: 11204592
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
[TBL] [Abstract][Full Text] [Related]
19. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.
van der Neut Kolfschoten M; Dirven RJ; Vos HL; Tans G; Rosing J; Bertina RM
J Biol Chem; 2004 Feb; 279(8):6567-75. PubMed ID: 14660667
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
Silveira JR; Kalafatis M; Tracy PB
Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
